Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
OncoCyte Community
NasdaqCM:OCX Community
1
Narratives
written by author
0
Comments
on narratives written by author
1
Fair Values set
on narratives written by author
Create a narrative
OncoCyte
Popular
Undervalued
Overvalued
Community Investing Ideas
OncoCyte
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
GraftAssure Assay Submissions Will Unlock Transplant Center Opportunities
Key Takeaways Strategic partnerships and anticipated regulatory approvals are poised to significantly expand OncoCyte's market reach, boosting revenue and supporting scalability. Fiscal discipline and funding increase operational sustainability, with reduced cash burn and a year-long financial runway enhancing long-term growth potential.
View narrative
US$4.42
FV
33.9% undervalued
intrinsic discount
91.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
OCX
OCX
OncoCyte
Your Fair Value
US$
Current Price
US$2.92
105.6% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-82m
14m
2015
2018
2021
2024
2025
2027
2030
Revenue US$14.4m
Earnings US$2.8m
Advanced
Set Fair Value